Summary

The population health management market is projected to reach USD 98.41 billion by 2031 from USD 46.93 billion in 2026, at a CAGR of 16.0%. Market growth is primarily driven by the increasing shift toward value-based care, the rising prevalence of chronic diseases, and the growing need to improve patient outcomes while reducing healthcare costs. Healthcare providers, payers, government agencies, and employers are increasingly adopting population health management solutions to identify high-risk populations, enhance care coordination, manage chronic conditions, and support preventive care initiatives. The integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data enables organizations to generate actionable insights, improve risk stratification, and deliver personalized care. Additionally, the growing adoption of cloud-based platforms, artificial intelligence (AI), predictive analytics, remote patient monitoring, and interoperable healthcare systems is strengthening population health management capabilities. As healthcare organizations continue to prioritize data-driven decision-making, care coordination, and value-based reimbursement models, demand for comprehensive PHM solutions is expected to accelerate throughout the forecast period.

The software segment accounted for a larger share of the population health management market in 2025.
Based on component, the population health management market has been segmented into software and services. The software segment accounted for a larger market share in 2025, driven by the widespread adoption of population health platforms for risk stratification, care management, predictive analytics, patient engagement, and clinical decision support. Healthcare providers and payers are increasingly investing in software solutions to integrate clinical, claims, pharmacy, and social determinants of health (SDOH) data, enabling real-time population insights and improved care coordination. The growing transition toward value-based care, increasing adoption of cloud-based PHM platforms, and rising demand for AI-enabled analytics and interoperability have further strengthened the dominance of the software segment in the population health management market.

The cloud-based segment is expected to exhibit the fastest growth during the forecast period.
Based on delivery mode, the population health management market has been segmented into cloud-based, on-premises, and hybrid models. Of these, the cloud-based segment is expected to record the fastest growth during the forecast period. This fast-paced growth is mainly driven by the increasing demand for scalable, cost-effective, and interoperable healthcare solutions that support value-based care initiatives. Cloud-based PHM platforms enable seamless integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data while providing real-time analytics, remote patient monitoring, and AI-driven insights. Their lower upfront costs, faster deployment, automatic software updates, and ability to securely share data across multiple care settings are encouraging widespread adoption among healthcare providers, payers, and public health organizations, making cloud-based deployment the fastest-growing segment in the population health management market.

Asia Pacific is expected to register the highest growth rate during the forecast period.
Asia Pacific is expected to witness the highest CAGR in the population health management market during the forecast period. This high growth rate is mainly supported by the rapid digitalization of healthcare systems, increasing government initiatives promoting healthcare IT adoption, rising prevalence of chronic diseases, and expanding investments in healthcare infrastructure across countries such as China, India, Japan, Australia, and South Korea. The growing adoption of electronic health records (EHRs), cloud-based healthcare platforms, AI-powered analytics, and remote patient monitoring solutions is enabling healthcare organizations to improve care coordination and population health outcomes. Furthermore, increasing awareness of preventive healthcare, expanding health insurance coverage, and the transition toward value-based care are accelerating the adoption of population health management solutions across the region, making Asia Pacific the fastest-growing regional market during the forecast period.

The breakdown of primary participants is as given below:
- By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
- By Designation - C-level: 55%, Director-level: 20%, and Others: 25%
- By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Latin America: 3%, Middle East & Africa: 2%

Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), Health Catalyst (US), and Optum Inc. (US) are some of the key players in the population health management market.

The study includes an in-depth competitive analysis of these key market players, with their company profiles, recent developments, and key market strategies.

Research Coverage
This research report categorizes the population health management market by component (Software, Services), functionality (Population Health Analytics, Care Management & Care Coordination, Risk Stratification & Predictive Analytics, Patient Engagement, Physician Engagement, Quality & Value-based Care Management, Interoperability & Data Integration, Others), delivery mode (Cloud-based, On-premises, Hybrid), organization size (Large Enterprises, Medium Enterprises, Small Enterprises), end user (Healthcare Providers [Hospitals & Health Systems, Physician Practices & Clinics, Other Healthcare Providers], Healthcare Payers [Private Payers, Public Payers], Government & Public Health Agencies, Employers, Life Sciences), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the population health management market. A detailed analysis of the key industry players has been done to provide insights into their business overview, software, and services; key strategies; and contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the population health management market. Competitive analysis of upcoming and established players in the population health management market ecosystem is covered in this report.

Reasons to Buy this Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the population health management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
- The report provides insights on the following pointers: Analysis of key drivers (Expansion of Value-based Care (VBC) and Risk-based Reimbursement Models, Growing Focus on Reducing Hospital Readmissions through Coordinated Care, Growing Adoption of Al-Driven Predictive Analytics within Healthcare Organizations, Increasing Availability of Interoperable Digital Health Data), restraints (Persistent Healthcare Data Interoperability Challenges, Rising Data Breach Concerns), opportunities (Integration of Social Determinants of Health (SDOH) into Population Health Strategies, Expansion of Remote Patient Monitoring and Virtual Care Programs, Growing Demand for Al-powered Care Management Automation), and challenges (Demonstrating Measurable Return on Investment (ROI), Clinical Workflow Integration and User Adoption) influencing the growth of the population health management market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the population health management market
- Market Development: Comprehensive information about lucrative markets; the report analyses the population health management market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the population health management market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and software offerings of leading players like Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), i2i Population Health (US), Health Catalyst (US), and Optum Inc. (US), among others, in the population health management market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 32
1.3.2 INCLUSIONS & EXCLUSIONS 33
1.3.3 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 LIMITATIONS 35
1.6 STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 36

2 EXECUTIVE SUMMARY 37
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 37
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 40
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42

3 PREMIUM INSIGHTS 43
3.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW 43
3.2 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT AND REGION 44
3.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT 44

4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 45
4.2.1 DRIVERS 46
4.2.1.1 Expansion of value-based care (VBC) and risk-based reimbursement models 46
4.2.1.2 Growing focus on reducing hospital readmissions through coordinated care 46
4.2.1.3 Growing adoption of Al-driven predictive analytics within healthcare organizations 47
4.2.1.4 Increasing availability of interoperable digital health data 47
4.2.2 RESTRAINTS 48
4.2.2.1 Persistent healthcare data interoperability challenges 48
4.2.2.2 Rising data breach concerns 48
4.2.3 OPPORTUNITIES 50
4.2.3.1 Integration of Social Determinants of Health (SDOH) into population health strategies 50
4.2.3.2 Expansion of remote patient monitoring and virtual care programs 51
4.2.3.3 Growing demand for AI-powered care management automation 51
4.2.4 CHALLENGES 52
4.2.4.1 Demonstrating measurable return on investment 52
4.2.4.2 Clinical workflow integration and user adoption 52
4.3 UNMET NEEDS AND WHITE SPACES 53
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 54

5 INDUSTRY TRENDS 56
5.1 PORTER’S FIVE FORCES ANALYSIS 56
5.1.1 BARGAINING POWER OF SUPPLIERS 57
5.1.2 BARGAINING POWER OF BUYERS 57
5.1.3 THREAT OF SUBSTITUTES 57
5.1.4 THREAT OF NEW ENTRANTS 57
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.2 MACROECONOMIC INDICATORS 58
5.2.1 INTRODUCTION 58
5.2.2 GDP TRENDS AND FORECAST 58
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 58
5.3 VALUE CHAIN ANALYSIS 59
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 60
5.3.2 TECHNOLOGY INPUTS & INFRASTRUCTURE 60
5.3.3 PLATFORM DEVELOPMENT & INTEGRATION 60
5.3.4 DISTRIBUTION 61
5.3.5 MARKETING & SALES 61
5.3.6 POST-SALES SERVICES 61
5.4 ECOSYSTEM ANALYSIS 61
5.5 PRICING ANALYSIS 63
5.5.1 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025) 63
5.5.2 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025) 64
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 65
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66
5.8 INVESTMENT AND FUNDING SCENARIO 67
5.9 CASE STUDY ANALYSIS 68
5.10 IMPACT OF 2025 US TARIFF – POPULATION HEALTH MANAGEMENT MARKET 69
5.10.1 INTRODUCTION 69
5.10.2 KEY TARIFF RATES 70
5.10.3 PRICE IMPACT ANALYSIS 71
5.10.4 IMPACT ON COUNTRY/REGION 71
5.10.4.1 US 71
5.10.4.2 Europe 71
5.10.4.3 Asia Pacific 72
5.10.5 IMPACT ON END USERS 72
5.10.5.1 Healthcare providers 72
5.10.5.2 Healthcare payers 72
5.10.5.3 Government & public health agencies 72
5.10.5.4 Employers 72
5.10.5.5 Life sciences 73

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.1.1 AI-POWERED PREDICTIVE ANALYTICS & RISK STRATIFICATION 74
6.1.2 GENERATIVE AI & CLINICAL DECISION SUPPORT 74
6.1.3 DIGITAL CARE MANAGEMENT & REMOTE PATIENT MONITORING (RPM) 74
6.2 COMPLEMENTARY TECHNOLOGIES 75
6.2.1 EHR, EMR, AND CLINICAL WORKFLOW INTEGRATION 75
6.2.2 HEALTHCARE DATA PLATFORMS & INTEROPERABILITY (FHIR, HL7, APIS) 75
6.3 ADJACENT TECHNOLOGIES 75
6.3.1 VALUE-BASED CARE & CARE COORDINATION PLATFORMS 75
6.3.2 SOCIAL DETERMINANTS OF HEALTH (SDOH) & COMMUNITY HEALTH PLATFORMS 76
6.4 TECHNOLOGY/PRODUCT ROADMAP 76
6.5 PATENT ANALYSIS 77
6.5.1 PATENT PUBLICATION TRENDS FOR POPULATION HEALTH MANAGEMENT MARKET 77
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 78
6.6 FUTURE APPLICATIONS 80
6.6.1 PRECISION POPULATION HEALTH & AI-DRIVEN RISK PREDICTION 80
6.6.2 CONTINUOUS CARE ECOSYSTEMS THROUGH REMOTE MONITORING & DIGITAL THERAPEUTICS 81
6.6.3 SOCIAL DETERMINANTS OF HEALTH (SDOH) INTELLIGENCE & COMMUNITY-BASED CARE ORCHESTRATION 81
6.7 IMPACT OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT MARKET 81
6.7.1 INTRODUCTION 81
6.7.2 MARKET POTENTIAL OF AI/GEN AI IN POPULATION HEALTH MANAGEMENT 82
6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 83
6.7.3.1 AI-powered claims management and revenue cycle optimization at Sentara Health 83
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84
6.7.4.1 Healthcare analytics market 84
6.7.4.2 Healthcare interoperability market 84
6.7.4.3 Remote patient monitoring market 85
6.7.5 USER READINESS AND IMPACT ASSESSMENT 85
6.7.5.1 User readiness 85
6.7.5.1.1 Healthcare providers 85
6.7.5.1.2 Healthcare payers 85
6.7.5.2 Impact assessment 85
6.7.5.2.1 User A: Healthcare providers 85
6.7.5.2.2 User B: Healthcare payers 86

7 REGULATORY LANDSCAPE 87
7.1 REGIONAL REGULATIONS AND COMPLIANCE 87
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
7.1.2 REGULATORY FRAMEWORK 91
7.1.2.1 North America 91
7.1.2.2 Europe 92
7.1.2.3 Asia Pacific 93
7.1.2.4 Latin America 94
7.1.2.5 Middle East & Africa 94
7.1.3 INDUSTRY STANDARDS 95

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96
8.1 INTRODUCTION 96
8.2 DECISION-MAKING PROCESS 96
8.3 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 97
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
8.3.2 BUYING CRITERIA 98
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 99
8.5 UNMET NEEDS FROM VARIOUS END USERS 99
8.5.1 UNMET NEEDS 100
8.5.2 END-USER EXPECTATIONS 101
8.6 MARKET PROFITABILITY 101

9 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT 102
9.1 INTRODUCTION 103
9.2 SOFTWARE 103
9.2.1 AI-POWERED ANALYTICS PLATFORMS PROPEL PHM SOFTWARE ADOPTION ACROSS VALUE-BASED ECOSYSTEMS 103
9.3 SERVICES 104
9.3.1 MANAGED CARE COORDINATION SERVICES BRIDGE TECHNOLOGY GAPS ACROSS FRAGMENTED HEALTH SYSTEMS 104

10 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY 106
10.1 INTRODUCTION 107
10.2 POPULATION HEALTH ANALYTICS 107
10.2.1 REAL-WORLD DATA INTEGRATION FUELS ACTIONABLE ANALYTICS ACROSS ENTIRE PATIENT POPULATIONS 107
10.3 CARE MANAGEMENT & CARE COORDINATION 108
10.3.1 ACO EXPANSION AND RISK-BEARING PAYMENT MODELS DRIVE INVESTMENT 108
10.4 RISK STRATIFICATION & PREDICTIVE ANALYTICS 109
10.4.1 PREDICTIVE AI MODELS ENABLE EARLIER INTERVENTION AND PRECISION RISK MANAGEMENT AT SCALE 109
10.5 PATIENT ENGAGEMENT 110
10.5.1 DIGITAL PATIENT ACTIVATION PROGRAMS CLOSE CARE GAPS AND IMPROVE CHRONIC DISEASE OUTCOMES 110
10.6 PHYSICIAN ENGAGEMENT 111
10.6.1 CLINICAL DECISION SUPPORT AND QUALITY DASHBOARDS EMBEDDING PHM INTO DAILY PHYSICIAN WORKFLOWS 111
10.7 QUALITY & VALUE-BASED CARE MANAGEMENT 112
10.7.1 RECORD ACO SAVINGS AND EXPANDED VBC INCENTIVES ACCELERATE QUALITY MANAGEMENT PLATFORM ADOPTION 112
10.8 INTEROPERABILITY & DATA INTEGRATION 113
10.8.1 TEFCA EXPANSION AND FHIR STANDARDS STRENGTHENING INFRASTRUCTURE FOR PHM DATA EXCHANGE 113
10.9 OTHER FUNCTIONALITIES 114
10.9.1 PUBLIC HEALTH SURVEILLANCE MODERNIZATION AND SDOH INTEGRATION EXPAND MARKET BOUNDARIES 114

11 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE 116
11.1 INTRODUCTION 117
11.2 CLOUD-BASED 117
11.2.1 INTEROPERABILITY MANDATES AND VBC SCALABILITY DEMANDS CEMENT CLOUD AS DOMINANT DELIVERY MODEL 117
11.3 ON-PREMISES 118
11.3.1 DATA SOVEREIGNTY, LEGACY INTEGRATION, AND REGULATORY COMPLIANCE SUSTAIN ON-PREMISES DEPLOYMENT 118
11.4 HYBRID 119
11.4.1 CLINICAL DATA CONTROL AND ANALYTICS SCALABILITY BALANCED THROUGH INTEGRATED HYBRID ARCHITECTURES 119

12 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE 121
12.1 INTRODUCTION 122
12.2 LARGE ENTERPRISES 122
12.2.1 ENTERPRISE-WIDE DIGITAL TRANSFORMATION AND VALUE-BASED CARE INITIATIVES DRIVE MARKET LEADERSHIP 122
12.3 MEDIUM ENTERPRISES 123
12.3.1 INCREASING PARTICIPATION IN VALUE-BASED CARE DRIVES DEMAND FOR SCALABLE PHM SOLUTIONS 123
12.4 SMALL ENTERPRISES 124
12.4.1 SUBSCRIPTION-BASED DEPLOYMENT MODELS IMPROVE PHM ACCESSIBILITY AND MARKET PENETRATION 124

13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER 126
13.1 INTRODUCTION 127
13.2 HEALTHCARE PROVIDERS 127
13.2.1 HOSPITALS & HEALTH SYSTEMS 128
13.2.1.1 Hospital digital transformation programs accelerate enterprise PHM platform deployment 128
13.2.2 PHYSICIAN PRACTICES & CLINICS 130
13.2.2.1 Independent practice value-based contracting creating scaled demand 130
13.2.3 OTHER HEALTHCARE PROVIDERS 131
13.2.3.1 Post-acute, behavioral health, and FQHC providers expand PHM market reach 131
13.3 HEALTHCARE PAYERS 131
13.3.1 RISK-BASED CONTRACTING EXPANSION AND CHRONIC DISEASE COST BURDEN DRIVE SEGMENT 131
13.3.2 PRIVATE PAYERS 133
13.3.2.1 Commercial VBC contracts and rising employer premiums accelerate adoption 133
13.3.3 PUBLIC PAYERS 134
13.3.3.1 CMS ACO expansion and Medicaid managed care growth reshaping public payer infrastructure 134
13.4 GOVERNMENT & PUBLIC HEALTH AGENCIES 135
13.4.1 PUBLIC HEALTH DATA MODERNIZATION AND GLOBAL DIGITAL HEALTH PROGRAMS BOOST GROWTH 135
13.5 EMPLOYERS 136
13.5.1 ESCALATING HEALTH BENEFIT COSTS AND CHRONIC DISEASE BURDEN COMPELLING EMPLOYER PHM PROGRAM INVESTMENT 136
13.6 LIFE SCIENCES 137
13.6.1 REAL-WORLD EVIDENCE GENERATION AND PATIENT RECRUITMENT DRIVE PHM PLATFORM ADOPTION 137

14 POPULATION HEALTH MANAGEMENT MARKET, BY REGION 138
14.1 INTRODUCTION 139
14.2 NORTH AMERICA 139
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143
14.2.2 US 144
14.2.2.1 Value-based care and digital health transformation drive population health management adoption 144
14.2.3 CANADA 147
14.2.3.1 Digital health modernization & interoperability accelerate market growth 147
14.3 EUROPE 151
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 155
14.3.2 GERMANY 155
14.3.2.1 Health data utilization and digital care reforms advance population health management 155
14.3.3 FRANCE 159
14.3.3.1 National health data ecosystem and preventive healthcare accelerates market growth 159
14.3.4 UK 162
14.3.4.1 Integrated care systems and population health analytics transforming healthcare delivery 162
14.3.5 ITALY 166
14.3.5.1 Community healthcare transformation and digital care continuity strengthen market growth 166
14.3.6 SPAIN 169
14.3.6.1 Regional integrated care networks and chronic disease management drives market expansion 169
14.3.7 REST OF EUROPE 173
14.4 ASIA PACIFIC 176
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 180
14.4.2 CHINA 181
14.4.2.1 Healthy China 2030 and AI-driven healthcare transformation accelerate market growth 181
14.4.3 JAPAN 184
14.4.3.1 Healthy aging and community-based integrated care drive healthcare transformation 184
14.4.4 INDIA 188
14.4.4.1 Ayushman Bharat and digital public health infrastructure drive integrated care delivery 188
14.4.5 AUSTRALIA 191
14.4.5.1 Primary healthcare networks and digital health initiatives drive preventive care 191
14.4.6 SOUTH KOREA 195
14.4.6.1 AI-enabled healthcare and digital health innovation drive personalized care 195
14.4.7 REST OF ASIA PACIFIC 198
14.5 LATIN AMERICA 201
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 205
14.5.2 BRAZIL 205
14.5.2.1 National Health Data Network (RNDS) and digital health transformation strengthen market 205
14.5.3 MEXICO 209
14.5.3.1 Electronic health record standardization and healthcare digitalization support market growth 209
14.5.4 REST OF LATIN AMERICA 212
14.6 MIDDLE EAST & AFRICA 215
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 216
14.6.2 GCC COUNTRIES 219
14.6.2.1 Saudi Arabia 223
14.6.2.1.1 Vision 2030 and AI-enabled healthcare transformation advancing population health management 223
14.6.2.2 UAE 226
14.6.2.2.1 AI-driven healthcare and national health data platforms accelerating population health management 226
14.6.2.3 Other GCC countries 230
14.6.2.3.1 National healthcare diversification creating opportunities for population health management 230
14.6.3 SOUTH AFRICA 233
14.6.3.1 National health insurance and primary healthcare reforms drive market 233
14.6.4 REST OF MIDDLE EAST & AFRICA 236

15 COMPETITIVE LANDSCAPE 240
15.1 INTRODUCTION 240
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 240
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET 241
15.3 REVENUE SHARE ANALYSIS, 2021–2025 242
15.4 MARKET SHARE ANALYSIS, 2025 243
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 245
15.5.1 STARS 246
15.5.2 PERVASIVE PLAYERS 246
15.5.3 EMERGING LEADERS 246
15.5.4 PARTICIPANTS 246
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 248
15.5.5.1 Company footprint 248
15.5.5.2 Region footprint 248
15.5.5.3 Component footprint 249
15.5.5.4 Functionality footprint 250
15.5.5.5 Delivery mode footprint 251
15.5.5.6 End user footprint 251
15.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025 252
15.6.1 PROGRESSIVE COMPANIES 252
15.6.2 DYNAMIC COMPANIES 252
15.6.3 STARTING BLOCKS 252
15.6.4 RESPONSIVE COMPANIES 253
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 254
15.7 COMPANY VALUATION & FINANCIAL METRICS 257
15.7.1 FINANCIAL METRICS 257
15.7.2 COMPANY VALUATION 257
15.8 BRAND/SOFTWARE COMPARISON ANALYSIS 258
15.9 COMPETITIVE SCENARIO 258
15.9.1 PRODUCT LAUNCHES & DEVELOPMENTS 258
15.9.2 DEALS 259
15.9.3 OTHER DEVELOPMENTS 260

16 COMPANY PROFILES 261
16.1 KEY PLAYERS 261
16.1.1 ORACLE 261
16.1.1.1 Business overview 261
16.1.1.2 Products offered 262
16.1.1.3 Recent developments 263
16.1.1.3.1 Product launches & approvals 263
16.1.1.3.2 Deals 263
16.1.1.3.3 Other developments 264
16.1.1.4 MnM view 264
16.1.1.4.1 Right to win 264
16.1.1.4.2 Strategic choices 264
16.1.1.4.3 Weaknesses & competitive threats 264
16.1.2 OPTUM, INC. 265
16.1.2.1 Business overview 265
16.1.2.2 Products offered 266
16.1.2.3 Recent developments 267
16.1.2.3.1 Deals 267
16.1.2.4 MnM view 267
16.1.2.4.1 Right to win 267
16.1.2.4.2 Strategic choices 267
16.1.2.4.3 Weaknesses & competitive threats 267
16.1.3 KONINKLIJKE PHILIPS N.V. 268
16.1.3.1 Business overview 268
16.1.3.2 Products offered 269
16.1.3.3 Recent developments 270
16.1.3.3.1 Product launches & approvals 270
16.1.3.3.2 Deals 271
16.1.3.4 MnM view 271
16.1.3.4.1 Right to win 271
16.1.3.4.2 Strategic choices 271
16.1.3.4.3 Weaknesses & competitive threats 272
16.1.4 EPIC SYSTEMS CORPORATION 273
16.1.4.1 Business overview 273
16.1.4.2 Products offered 273
16.1.4.3 Recent developments 274
16.1.4.3.1 Product launches & approvals 274
16.1.4.3.2 Deals 274
16.1.4.4 MnM view 275
16.1.4.4.1 Right to win 275
16.1.4.4.2 Strategic choices 275
16.1.4.4.3 Weaknesses & competitive threats 275
16.1.5 MERATIVE 276
16.1.5.1 Business overview 276
16.1.5.2 Products offered 277
16.1.5.3 Recent developments 277
16.1.5.3.1 Deals 277
16.1.5.3.2 Expansions 278
16.1.5.4 MnM view 278
16.1.5.4.1 Right to win 278
16.1.5.4.2 Strategic choices 278
16.1.5.4.3 Weaknesses & competitive threats 278
16.1.6 VERADIGM LLC 279
16.1.6.1 Business overview 279
16.1.6.2 Products offered 280
16.1.6.3 Recent developments 281
16.1.6.3.1 Deals 281
16.1.6.3.2 Other developments 281
16.1.7 I2I POPULATION HEALTH 282
16.1.7.1 Business overview 282
16.1.7.2 Products offered 283
16.1.7.3 Recent developments 283
16.1.7.3.1 Deals 283
16.1.8 HEALTH CATALYST 284
16.1.8.1 Business overview 284
16.1.8.2 Products offered 285
16.1.8.3 Recent developments 286
16.1.8.3.1 Product launches & approvals 286
16.1.8.3.2 Deals 286
16.1.9 CEDAR GATE TECHNOLOGIES 287
16.1.9.1 Business overview 287
16.1.9.2 Products offered 287
16.1.9.3 Recent developments 288
16.1.9.3.1 Product launches & approvals 288
16.1.10 ECLINICALWORKS 289
16.1.10.1 Business overview 289
16.1.10.2 Products offered 289
16.1.10.3 Recent developments 290
16.1.10.3.1 Product launches & approvals 290
16.1.11 ELLIGINT HEALTH 291
16.1.11.1 Business overview 291
16.1.11.2 Products offered 292
16.1.12 MEDECISION 293
16.1.12.1 Business overview 293
16.1.12.2 Products offered 293
16.1.12.3 Recent developments 294
16.1.12.3.1 Product launches & approvals 294
16.1.12.3.2 Deals 295
16.1.13 ARCADIA 296
16.1.13.1 Business overview 296
16.1.13.2 Products offered 296
16.1.13.3 Recent developments 297
16.1.13.3.1 Deals 297
16.1.14 ATHENAHEALTH 298
16.1.14.1 Business overview 298
16.1.14.2 Products offered 298
16.1.14.3 Recent developments 299
16.1.14.3.1 Deals 299
16.1.15 COTIVITI, INC. 300
16.1.15.1 Business overview 300
16.1.15.2 Products offered 300
16.1.15.3 Recent developments 301
16.1.15.3.1 Deals 301
16.1.15.3.2 Other developments 301
16.1.16 NXGN MANAGEMENT, LLC. (NEXTGEN HEALTHCARE) 302
16.1.16.1 Business overview 302
16.1.16.2 Products offered 303
16.2 OTHER PLAYERS 304
16.2.1 MEDEANALYTICS, INC. 304
16.2.2 CONIFER HEALTH SOLUTIONS 305
16.2.3 LIGHTBEAM HEALTH SOLUTIONS 306
16.2.4 INNOVACCER 307
16.2.5 LUMERIS 308
16.2.6 ZEOMEGA 309
16.2.7 MILLIMAN MEDINSIGHT (A MILLIMAN COMPANY) 310
16.2.8 PERSIVIA 311
16.2.9 COLOR HEALTH, INC. 312

17 RESEARCH METHODOLOGY 313
17.1 RESEARCH APPROACH 313
17.1.1 SECONDARY RESEARCH 313
17.1.1.1 Key data from secondary sources 314
17.1.2 PRIMARY RESEARCH 315
17.1.2.1 Primary sources 315
17.1.2.2 Key data from primary sources 316
17.1.2.3 Breakdown of primaries 316
17.1.2.4 Insights from primary experts 317
17.2 RESEARCH METHODOLOGY 317
17.3 MARKET SIZE ESTIMATION 318
17.4 MARKET BREAKDOWN DATA TRIANGULATION 323
17.5 MARKET SHARE ESTIMATION 324
17.6 STUDY ASSUMPTIONS 324
17.7 RESEARCH LIMITATIONS 324
17.7.1 METHODOLOGY-RELATED LIMITATIONS 324
17.8 RISK ASSESSMENT 325

18 APPENDIX 326
18.1 DISCUSSION GUIDE 326
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 331
18.3 CUSTOMIZATION OPTIONS 333
18.4 RELATED REPORTS 333
18.5 AUTHOR DETAILS 334

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET SEGMENTATION 32.
FIGURE 2 MARKET SCENARIO 38.
FIGURE 3 GLOBAL POPULATION HEALTH MANAGEMENT MARKET, 2024–2031 38.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2023–2026 39.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POPULATION HEALTH MANAGEMENT MARKET 40.
FIGURE 6 HIGH-GROWTH SEGMENTS IN POPULATION HEALTH MANAGEMENT MARKET, 2026–2031 41.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POPULATION HEALTH MANAGEMENT MARKET DURING FORECAST PERIOD 42.
FIGURE 8 VALUE-BASED CARE AND HEALTHCARE DIGITALIZATION ACCELERATING GROWTH IN POPULATION HEALTH MANAGEMENT MARKET 43.
FIGURE 9 SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA.
IN 2025 44.
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 44.
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45.
FIGURE 12 HEALTHCARE DATA BREACH ATTACK VECTORS, 2025 49.
FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 56.
FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 60.
FIGURE 15 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS 62.
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67.
FIGURE 18 PATENT PUBLICATION TRENDS IN POPULATION HEALTH MANAGEMENT MARKET, 2015–2026 77.
FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR POPULATION HEALTH MANAGEMENT MARKET 78.
FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2015 TO JULY 2026) 79.
FIGURE 21 MARKET POTENTIAL OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT SOLUTIONS ACROSS INDUSTRIES 82.
FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84.
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 97.
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 98.
FIGURE 25 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 140.
FIGURE 26 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT 177.
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2021–2025 (USD BILLION) 243.
FIGURE 28 POPULATION HEALTH MANAGEMENT: MARKET SHARE ANALYSIS, 2025 244.
FIGURE 29 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 247.
FIGURE 30 POPULATION HEALTH MANAGEMENT MARKET: COMPANY FOOTPRINT 248.
FIGURE 31 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 253.
FIGURE 32 EV/EBITDA OF KEY VENDORS 257.
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF POPULATION HEALTH MANAGEMENT SOLUTION VENDORS 257.
FIGURE 34 POPULATION HEALTH MANAGEMENT MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 258.
FIGURE 35 ORACLE: COMPANY SNAPSHOT (2025) 262.
FIGURE 36 OPTUM, INC.: COMPANY SNAPSHOT (2025) 266.
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 269.
FIGURE 38 VERADIGM LLC: COMPANY SNAPSHOT (2025) 280.
FIGURE 39 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 285.
FIGURE 40 RESEARCH DESIGN 313.
FIGURE 41 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,.
AND REGION 316.
FIGURE 42 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 318.
FIGURE 43 BOTTOM-UP APPROACH 319.
FIGURE 44 TOP-DOWN APPROACH 319.
FIGURE 45 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POPULATION HEALTH MANAGEMENT SOLUTIONS INDUSTRY 320.
FIGURE 46 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 321.
FIGURE 47 DATA TRIANGULATION METHODOLOGY 323.
TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD 34.
TABLE 2 US: BIGGEST HEALTHCARE DATA BREACHES OF 2025 49.
TABLE 3 HEALTHCARE EDI MARKET: PORTER’S FIVE FORCES ANALYSIS 57.
TABLE 4 POPULATION HEALTH MANAGEMENT MARKET: ROLE IN ECOSYSTEM 62.
TABLE 5 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS,.
BY COMPONENT (2025) 64.
TABLE 6 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS,.
BY REGION (2025) 65.
TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: KEY CONFERENCES & EVENTS, 2026–2027 65.
TABLE 8 CASE 1: ACCELERATED VALUE-BASED CARE DELIVERY WITH AI-DRIVEN POPULATION HEALTH MANAGEMENT 68.
TABLE 9 CASE 2: IMPROVED COMMUNITY HEALTH THROUGH DATA-DRIVEN POPULATION HEALTH ANALYTICS 68.
TABLE 10 CASE 3: REDUCED EMERGENCY DEPARTMENT VISITS THROUGH AI-ENABLED POPULATION HEALTH MANAGEMENT 69.
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES 70.
TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR POPULATION HEALTH MANAGEMENT MARKET 78.
TABLE 13 POPULATION HEALTH MANAGEMENT MARKET: KEY PATENTS/PATENT APPLICATIONS 79.
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88.
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88.
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89.
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90.
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90.
TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA 91.
TABLE 20 REGULATORY SCENARIO OF EUROPE 92.
TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC 93.
TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA 94.
TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 94.
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE.
END USERS (%) 98.
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 99.
TABLE 26 UNMET NEEDS IN POPULATION HEALTH MANAGEMENT MARKET 100.
TABLE 27 END-USER EXPECTATIONS IN POPULATION HEALTH MANAGEMENT MARKET 101.
TABLE 28 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 103.
TABLE 29 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY REGION,.
2024–2031 (USD MILLION) 104.
TABLE 30 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY REGION,.
2024–2031 (USD MILLION) 105.
TABLE 31 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 107.
TABLE 32 POPULATION HEALTH ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 108.
TABLE 33 CARE MANAGEMENT & CARE COORDINATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 109.
TABLE 34 RISK STRATIFICATION & PREDICTIVE ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 110.
TABLE 35 PATIENT ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET,.
BY REGION, 2024–2031 (USD MILLION) 111.
TABLE 36 PHYSICIAN ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET,.
BY REGION, 2024–2031 (USD MILLION) 112.
TABLE 37 QUALITY & VALUE-BASED CARE MANAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 113.
TABLE 38 INTEROPERABILITY & DATA INTEGRATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 114.
TABLE 39 OTHER FUNCTIONALITIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY REGION, 2024–2031 (USD MILLION) 115.
TABLE 40 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 117.
TABLE 41 CLOUD-BASED: POPULATION HEALTH MANAGEMENT MARKET, BY REGION,.
2024–2031 (USD MILLION) 118.
TABLE 42 ON-PREMISES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION,.
2024–2031 (USD MILLION) 119.
TABLE 43 HYBRID: POPULATION HEALTH MANAGEMENT MARKET, BY REGION,.
2024–2031 (USD MILLION) 120.
TABLE 44 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE,.
2024–2031 (USD MILLION) 122.
TABLE 45 POPULATION HEALTH MANAGEMENT MARKET FOR LARGE ENTERPRISES,.
BY REGION, 2024–2031 (USD MILLION) 123.
TABLE 46 POPULATION HEALTH MANAGEMENT MARKET FOR MEDIUM ENTERPRISES,.
BY REGION, 2024–2031 (USD MILLION) 124.
TABLE 47 POPULATION HEALTH MANAGEMENT MARKET FOR SMALL ENTERPRISES,.
BY REGION, 2024–2031 (USD MILLION) 125.
TABLE 48 POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 127.
TABLE 49 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 128.
TABLE 50 HEALTHCARE PROVIDERS: POPULATION HEALTH MANAGEMENT MARKET,.
BY REGION, 2024–2031 (USD MILLION) 128.
TABLE 51 POPULATION HEALTH MANAGEMENT MARKET FOR HOSPITALS AND HEALTH SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 129.
TABLE 52 POPULATION HEALTH MANAGEMENT MARKET FOR PHYSICIAN PRACTICES & CLINICS, BY REGION, 2024–2031 (USD MILLION) 130.
TABLE 53 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 131.
TABLE 54 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER,.
2024–2031 (USD MILLION) 132.
TABLE 55 HEALTHCARE PAYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 132.
TABLE 56 POPULATION HEALTH MANAGEMENT MARKET FOR PRIVATE PAYERS, BY REGION, 2024–2031 (USD MILLION) 133.
TABLE 57 POPULATION HEALTH MANAGEMENT MARKET FOR PUBLIC PAYERS, BY REGION, 2024–2031 (USD MILLION) 134.
TABLE 58 GOVERNMENT & PUBLIC HEALTH AGENCIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 135.
TABLE 59 EMPLOYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION,.
2024–2031 (USD MILLION) 136.
TABLE 60 LIFE SCIENCES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 137.
TABLE 61 POPULATION HEALTH MANAGEMENT MARKET, BY REGION,.
2024–2031 (USD MILLION) 139.
TABLE 62 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140.
TABLE 63 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 141.
TABLE 64 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 141.
TABLE 65 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 142.
TABLE 66 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 142.
TABLE 67 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 142.
TABLE 68 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 143.
TABLE 69 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 143.
TABLE 70 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 145.
TABLE 71 US: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 145.
TABLE 72 US: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 146.
TABLE 73 US: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 146.
TABLE 74 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 146.
TABLE 75 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 147.
TABLE 76 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 147.
TABLE 77 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 148.
TABLE 78 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 149.
TABLE 79 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 149.
TABLE 80 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 150.
TABLE 81 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 150.
TABLE 82 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 150.
TABLE 83 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 151.
TABLE 84 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 152.
TABLE 85 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 152.
TABLE 86 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 153.
TABLE 87 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 153.
TABLE 88 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 154.
TABLE 89 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 154.
TABLE 90 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 154.
TABLE 91 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 155.
TABLE 92 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 156.
TABLE 93 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 157.
TABLE 94 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 157.
TABLE 95 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 158.
TABLE 96 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 158.
TABLE 97 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 158.
TABLE 98 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 159.
TABLE 99 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 160.
TABLE 100 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 160.
TABLE 101 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 161.
TABLE 102 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 161.
TABLE 103 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 161.
TABLE 104 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 162.
TABLE 105 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 162.
TABLE 106 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 163.
TABLE 107 UK: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 164.
TABLE 108 UK: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 164.
TABLE 109 UK: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 165.
TABLE 110 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 165.
TABLE 111 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 165.
TABLE 112 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 166.
TABLE 113 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 167.
TABLE 114 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 167.
TABLE 115 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 168.
TABLE 116 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 168.
TABLE 117 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 168.
TABLE 118 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 169.
TABLE 119 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 169.
TABLE 120 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 170.
TABLE 121 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 171.
TABLE 122 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 171.
TABLE 123 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 172.
TABLE 124 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 172.
TABLE 125 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 172.
TABLE 126 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 173.
TABLE 127 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 174.
TABLE 128 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 174.
TABLE 129 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 175.
TABLE 130 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 175.
TABLE 131 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 175.
TABLE 132 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 176.
TABLE 133 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 176.
TABLE 134 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 177.
TABLE 135 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 178.
TABLE 136 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 178.
TABLE 137 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 179.
TABLE 138 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 179.
TABLE 139 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 179.
TABLE 140 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 180.
TABLE 141 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 180.
TABLE 142 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 182.
TABLE 143 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 182.
TABLE 144 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 183.
TABLE 145 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 183.
TABLE 146 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 183.
TABLE 147 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 184.
TABLE 148 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 184.
TABLE 149 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 185.
TABLE 150 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 186.
TABLE 151 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 186.
TABLE 152 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 187.
TABLE 153 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 187.
TABLE 154 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 187.
TABLE 155 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 188.
TABLE 156 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 189.
TABLE 157 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 189.
TABLE 158 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 190.
TABLE 159 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 190.
TABLE 160 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 190.
TABLE 161 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 191.
TABLE 162 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 191.
TABLE 163 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 192.
TABLE 164 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 193.
TABLE 165 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 193.
TABLE 166 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 194.
TABLE 167 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 194.
TABLE 168 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 194.
TABLE 169 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 195.
TABLE 170 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 196.
TABLE 171 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 196.
TABLE 172 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 197.
TABLE 173 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 197.
TABLE 174 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 197.
TABLE 175 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 198.
TABLE 176 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 198.
TABLE 177 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY COMPONENT, 2024–2031 (USD MILLION) 199.
TABLE 178 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 199.
TABLE 179 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY DELIVERY MODE, 2024–2031 (USD MILLION) 200.
TABLE 180 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 200.
TABLE 181 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 200.
TABLE 182 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 201.
TABLE 183 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 201.
TABLE 184 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202.
TABLE 185 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 202.
TABLE 186 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 203.
TABLE 187 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 203.
TABLE 188 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 204.
TABLE 189 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 204.
TABLE 190 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 204.
TABLE 191 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 205.
TABLE 192 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 206.
TABLE 193 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 207.
TABLE 194 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 207.
TABLE 195 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 208.
TABLE 196 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 208.
TABLE 197 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 208.
TABLE 198 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 209.
TABLE 199 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 210.
TABLE 200 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 210.
TABLE 201 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 211.
TABLE 202 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 211.
TABLE 203 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 211.
TABLE 204 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 212.
TABLE 205 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 212.
TABLE 206 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY COMPONENT, 2024–2031 (USD MILLION) 213.
TABLE 207 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 213.
TABLE 208 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY DELIVERY MODE, 2024–2031 (USD MILLION) 214.
TABLE 209 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 214.
TABLE 210 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 214.
TABLE 211 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 215.
TABLE 212 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 215.
TABLE 213 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 216.
TABLE 214 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY COMPONENT, 2024–2031 (USD MILLION) 217.
TABLE 215 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 217.
TABLE 216 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY DELIVERY MODE, 2024–2031 (USD MILLION) 218.
TABLE 217 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 218.
TABLE 218 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 218.
TABLE 219 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 219.
TABLE 220 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 219.
TABLE 221 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 220.
TABLE 222 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 220.
TABLE 223 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 221.
TABLE 224 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 221.
TABLE 225 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 222.
TABLE 226 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 222.
TABLE 227 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 222.
TABLE 228 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 223.
TABLE 229 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 224.
TABLE 230 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 224.
TABLE 231 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 225.
TABLE 232 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 225.
TABLE 233 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 225.
TABLE 234 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 226.
TABLE 235 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 226.
TABLE 236 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT,.
2024–2031 (USD MILLION) 227.
TABLE 237 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY,.
2024–2031 (USD MILLION) 228.
TABLE 238 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE,.
2024–2031 (USD MILLION) 228.
TABLE 239 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 229.
TABLE 240 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER,.
2024–2031 (USD MILLION) 229.
TABLE 241 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 229.
TABLE 242 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 230.
TABLE 243 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY COMPONENT, 2024–2031 (USD MILLION) 231.
TABLE 244 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY FUNCTIONALITY, 2024–2031 (USD MILLION) 231.
TABLE 245 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY DELIVERY MODE, 2024–2031 (USD MILLION) 232.
TABLE 246 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 232.
TABLE 247 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 232.
TABLE 248 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 233.
TABLE 249 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET,.
BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 233.
TABLE 250 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 234.
TABLE 251 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 234.
TABLE 252 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 235.
TABLE 253 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 235.
TABLE 254 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 235.
TABLE 255 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 236.
TABLE 256 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 236.
TABLE 257 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 237.
TABLE 258 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION) 237.
TABLE 259 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION) 238.
TABLE 260 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024–2031 (USD MILLION) 238.
TABLE 261 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 238.
TABLE 262 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 239.
TABLE 263 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 239.
TABLE 264 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 241.
TABLE 265 POPULATION HEALTH MANAGEMENT MARKET: DEGREE OF COMPETITION 244.
TABLE 266 POPULATION HEALTH MANAGEMENT MARKET: REGION FOOTPRINT 248.
TABLE 267 POPULATION HEALTH MANAGEMENT MARKET: COMPONENT FOOTPRINT 249.
TABLE 268 POPULATION HEALTH MANAGEMENT MARKET: FUNCTIONALITY ANALYSIS 250.
TABLE 269 POPULATION HEALTH MANAGEMENT MARKET: DELIVERY MODE FOOTPRINT 251.
TABLE 270 END USER FOOTPRINT ANALYSIS 251.
TABLE 271 POPULATION HEALTH MANAGEMENT MARKET: DETAILED LIST OF KEY START-UPS/SMES 254.
TABLE 272 KEY EMERGING PLAYERS/STARTUPS: REGION FOOTPRINT 254.
TABLE 273 KEY EMERGING PLAYERS/STARTUPS: COMPONENT FOOTPRINT 255.
TABLE 274 KEY EMERGING PLAYERS/STARTUPS: FUNCTIONALITY FOOTPRINT 255.
TABLE 275 KEY EMERGING PLAYERS/STARTUPS: DELIVERY MODE FOOTPRINT 256.
TABLE 276 KEY EMERGING PLAYERS/STARTUPS: END USER FOOTPRINT 256.
TABLE 277 POPULATION HEALTH MANAGEMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 258.
TABLE 278 POPULATION HEALTH MANAGEMENT MARKET: DEALS, JANUARY 2023–JULY 2026 259.
TABLE 279 POPULATION HEALTH MANAGEMENT MARKET: OTHER DEVELOPMENTS,.
JANUARY 2023–JULY 2026 260.
TABLE 280 ORACLE: COMPANY OVERVIEW 261.
TABLE 281 ORACLE: PRODUCTS OFFERED 262.
TABLE 282 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 263.
TABLE 283 ORACLE: DEALS, JANUARY 2023–JULY 2026 263.
TABLE 284 ORACLE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 264.
TABLE 285 OPTUM INC.: COMPANY OVERVIEW 265.
TABLE 286 OPTUM, INC.: PRODUCTS OFFERED 266.
TABLE 287 OPTUM, INC.: DEALS, JANUARY 2023–JULY 2026 267.
TABLE 288 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 268.
TABLE 289 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 269.
TABLE 290 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,.
JANUARY 2023–JULY 2026 270.
TABLE 291 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–JULY 2026 271.